Cargando…
Pharmacoepidemiological Evaluation in Prostate Cancer—Common Pitfalls and How to Avoid Them
SIMPLE SUMMARY: Pharmacoepidemiologic research provides opportunities to evaluate how commonly used drug groups, such as cholesterol-lowering drugs, may affect the prostate cancer risk or mortality. However, such studies need to be carefully designed in order to avoid biases caused by systematic dif...
Autores principales: | Siltari, Aino, Auvinen, Anssi, Murtola, Teemu J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7914977/ https://www.ncbi.nlm.nih.gov/pubmed/33572236 http://dx.doi.org/10.3390/cancers13040696 |
Ejemplares similares
-
Antihypertensive drug use and prostate cancer-specific mortality in Finnish men
por: Siltari, Aino, et al.
Publicado: (2020) -
Role of Lipids and Lipid Metabolism in Prostate Cancer Progression and the Tumor’s Immune Environment
por: Siltari, Aino, et al.
Publicado: (2022) -
Pitfalls in compressed sensing reconstruction and how to avoid them
por: Shchukina, Alexandra, et al.
Publicado: (2016) -
Digoxin and prostate cancer survival in the Finnish Randomized Study of Screening for Prostate Cancer
por: Kaapu, Kalle J, et al.
Publicado: (2016) -
Anti-epileptic drugs and prostate cancer-specific mortality compared to non-users of anti-epileptic drugs in the Finnish Randomized Study of Screening for Prostate Cancer
por: Salminen, Jukka K., et al.
Publicado: (2022)